ALGS   $1.09  -1.41% Market Closed

Aligos Therapeutics Inc
Total Cash 135.70M
totalCashPerShare 1.793
EBITDA -85.84M
Total Debt 11.14M
quickRatio 5.677
currentRatio 5.902
Total Revenue 15.53M
debtToEquity 12.096
Revenue/Share 0.242
ROA -0.36635
ROE -0.89476997
grossProfits
freeCashflow -45.91M
operatingCashflow -79.00M
earningsGrowth
revenueGrowth -0.242
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -9.42671
profitMargins 0.0
enterpriseValue -50.49M
forwardPE -1.195122
floatShares 36.68M
sharesOutstanding 72.58M
sharesShort 365.60K
sharesShortPriorMonth 317.13K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.21%
heldPercentInstitutions 0.62%
Short Ratio help_outline 0.56%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 1.226
Price To Book help_outline 0.80
earningsQuarterlyGrowth
netIncomeToCommon -87.68M
trailingEps -1.36%
forwardEps -0.82%
enterpriseToEbitda 0.59
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.19 1Q 2024
institutionsCount 49
lastUpdated April 1, 2024, 2:50 p.m.